NeuroOne Awards 10,000 Options at $3.27, Vesting Over Four Years
NMTC•NeuroOne granted an option award of 10,000 shares at $3.27 per share under Nasdaq Rule 5635(c)(4) to a new executive, effective June 24, 2026. The ten-year option vests over four years, with 25% vesting on June 24, 2027 and the remainder in quarterly installments, subject to acceleration or forfeiture.
1. Grant Approval and Purpose
NeuroOne's independent directors approved an inducement equity award under the 2021 Inducement Plan to incentivize a new executive hire. This grant aligns with Nasdaq Listing Rule 5635(c)(4) requirements for awards outside a shareholder-approved plan.
2. Option Award Terms
The new hire received an option to purchase 10,000 shares at an exercise price of $3.27 per share, equal to the closing price on June 24, 2026. The option carries a ten-year term from the grant date.
3. Vesting Schedule and Conditions
Twenty-five percent of the award vests on June 24, 2027, with the remaining 75% vesting in twelve equal quarterly installments thereafter. Vesting is contingent on continued employment and subject to acceleration or forfeiture upon specified triggering events.
